Planet 13 Holdings (PLNH) Other Non-Current Assets (2021 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Other Non-Current Assets of $898725.0 for Q1 2026, down 80.34% year-over-year from $4.6 million in Q1 2025, and up 8.39% quarter-over-quarter from $829164.0 in Q4 2025.
Planet 13 Holdings (PLNH) Other Non-Current Assets (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Other Non-Current Assets for 6 consecutive years, with $898725.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 80.34% year-over-year to $898725.0; the TTM figure through Mar 2026 stood at $898725.0 (down 80.34% YoY), while the FY2025 annual figure was $829164.0, up 575.0% from the prior year.
- Other Non-Current Assets improved to $898725.0 in Q1 2026 per PLNH's latest filing, from $829164.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $9.0 million in Q4 2023 and bottomed at $122839.0 in Q4 2024.
- Historically, Other Non-Current Assets has averaged $1.4 million across 5 years, with a median of $862545.0 in 2022.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets soared 943.42% — and 2024, when it slumped 98.64%.
- Planet 13 Holdings' Other Non-Current Assets stood at $862545.0 in 2022, then jumped by 943.42% to $9.0 million in 2023, then plunged by 98.64% to $122839.0 in 2024, then surged by 575.0% to $829164.0 in 2025, then climbed by 8.39% to $898725.0 in 2026.
- Business Quant data shows PLNH's Other Non-Current Assets at $898725.0 in Q1 2026, $829164.0 in Q4 2025, and $180207.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 13.00 Mn |
| 10 | Planet 13 Holdings | 52.64 Mn | 36.16 Mn | 12.32 Mn | 897,762.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 897,762.00 |
| Mar 31, 2026 | 898,725.00 |
| Dec 31, 2025 | 829,164.00 |
| Sep 30, 2025 | 180,207.00 |
| Jun 30, 2025 | 266,652.00 |
| Mar 31, 2025 | 4.57 Mn |
| Dec 31, 2024 | 122,839.00 |
| Sep 30, 2024 | 264,431.00 |
| Jun 30, 2024 | 989,376.00 |
| Mar 31, 2024 | 470,256.00 |
| Dec 31, 2023 | 9.00 Mn |
| Sep 30, 2023 | 832,853.00 |
| Jun 30, 2023 | 1.05 Mn |
| Mar 31, 2023 | 862,545.00 |
| Dec 31, 2022 | 862,545.00 |
| Sep 30, 2022 | 1.02 Mn |
| Jun 30, 2022 | 1.02 Mn |
| Mar 31, 2022 | 1.23 Mn |
| Dec 31, 2021 | 1.06 Mn |